BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 18759521)

  • 1. High expression of minichromosome maintenance protein 6 in classic Hodgkin's lymphoma points to a cell cycle arrest in G1 phase.
    Karimi S; Mohammadi F; Khodadad K; Emami H; Seyfollahi L
    Arch Iran Med; 2008 Sep; 11(5):532-8. PubMed ID: 18759521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proliferation characteristics in pediatric Hodgkin's lymphoma point to a cell cycle arrest in the G(1) phase.
    Tiemann M; Claviez A; Lüders H; Zimmermann M; Schellong G; Dörffel W; Parwaresch R
    Mod Pathol; 2005 Nov; 18(11):1440-7. PubMed ID: 16056247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minichromosome maintenance protein 6, a proliferation marker superior to Ki-67 and independent predictor of survival in patients with mantle cell lymphoma.
    Schrader C; Janssen D; Klapper W; Siebmann JU; Meusers P; Brittinger G; Kneba M; Tiemann M; Parwaresch R
    Br J Cancer; 2005 Oct; 93(8):939-45. PubMed ID: 16189522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant expression of cell cycle regulators in Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma.
    Tzankov A; Zimpfer A; Went P; Maurer R; Pileri SA; Geley S; Dirnhofer S
    Mod Pathol; 2005 Jan; 18(1):90-6. PubMed ID: 15389259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fascin, a sensitive new marker for Reed-Sternberg cells of hodgkin's disease. Evidence for a dendritic or B cell derivation?
    Pinkus GS; Pinkus JL; Langhoff E; Matsumura F; Yamashiro S; Mosialos G; Said JW
    Am J Pathol; 1997 Feb; 150(2):543-62. PubMed ID: 9033270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of common germinal-center B-cell precursors in two patients with both Hodgkin's disease and non-Hodgkin's lymphoma.
    Bräuninger A; Hansmann ML; Strickler JG; Dummer R; Burg G; Rajewsky K; Küppers R
    N Engl J Med; 1999 Apr; 340(16):1239-47. PubMed ID: 10210707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-invasive detection of genomic imbalances in Hodgkin/Reed-Sternberg cells in early and advanced stage Hodgkin's lymphoma by sequencing of circulating cell-free DNA: a technical proof-of-principle study.
    Vandenberghe P; Wlodarska I; Tousseyn T; Dehaspe L; Dierickx D; Verheecke M; Uyttebroeck A; Bechter O; Delforge M; Vandecaveye V; Brison N; Verhoef GE; Legius E; Amant F; Vermeesch JR
    Lancet Haematol; 2015 Feb; 2(2):e55-65. PubMed ID: 26687610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular endothelial growth factor (VEGF) is expressed by neoplastic Hodgkin-Reed-Sternberg cells in Hodgkin's disease.
    Doussis-Anagnostopoulou IA; Talks KL; Turley H; Debnam P; Tan DC; Mariatos G; Gorgoulis V; Kittas C; Gatter KC
    J Pathol; 2002 Aug; 197(5):677-83. PubMed ID: 12210089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hodgkin's disease with monoclonal and polyclonal populations of Reed-Sternberg cells.
    Hummel M; Ziemann K; Lammert H; Pileri S; Sabattini E; Stein H
    N Engl J Med; 1995 Oct; 333(14):901-6. PubMed ID: 7545266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proliferation of Reed-Sternberg cells and variants in Hodgkin's disease.
    Gupta RK; Lister TA; Bodmer JG
    Ann Oncol; 1994; 5 Suppl 1():117-9. PubMed ID: 8172808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical comparative investigations of lymphatic tissue in reactive processes, myasthenic thymuses and Hodgkin's disease.
    Zółtowska A
    Arch Immunol Ther Exp (Warsz); 1995; 43(1):15-22. PubMed ID: 8744679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical drug-resistant nodular sclerosing Hodgkin's lymphoma is associated with decreased bcl-2 expression in the surrounding lymphocytes and with increased bcl-2 expression in the Reed-Sternberg cells.
    van Spronsen DJ; Peh SC; Vrints LW; van Imhoff GW; Poppema S
    Histopathology; 2000 Nov; 37(5):420-6. PubMed ID: 11119123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant FHIT protein expression in classical Hodgkin's lymphoma: a potential marker.
    Zhao P; Lam AK; Lu YL; Zhong M; Chen LH; Pu XL
    Pathology; 2006 Oct; 38(5):399-402. PubMed ID: 17008276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of proliferating cell nuclear antigen (PCNA) and p53, bcl-2 or C-erb B-2 proteins on Reed-Sternberg cells: prognostic significance in Hodgkin's disease.
    Smolewski P; Niewiadomska H; Błonski JZ; Robak T; Krykowski E
    Neoplasma; 1998; 45(3):140-7. PubMed ID: 9717525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization and expression of CT45 in Hodgkin's lymphoma.
    Heidebrecht HJ; Claviez A; Kruse ML; Pollmann M; Buck F; Harder S; Tiemann M; Dörffel W; Parwaresch R
    Clin Cancer Res; 2006 Aug; 12(16):4804-11. PubMed ID: 16914565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of heat shock protein 90 function by 17-allylamino-17-demethoxy-geldanamycin in Hodgkin's lymphoma cells down-regulates Akt kinase, dephosphorylates extracellular signal-regulated kinase, and induces cell cycle arrest and cell death.
    Georgakis GV; Li Y; Rassidakis GZ; Martinez-Valdez H; Medeiros LJ; Younes A
    Clin Cancer Res; 2006 Jan; 12(2):584-90. PubMed ID: 16428504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proliferation profile of classical Hodgkin's lymphomas. Increased expression of the protein cyclin D2 in Hodgkin's and Reed-Sternberg cells.
    Bai M; Tsanou E; Agnantis NJ; Kamina S; Grepi C; Stefanaki K; Rontogianni D; Galani V; Kanavaros P
    Mod Pathol; 2004 Nov; 17(11):1338-45. PubMed ID: 15354186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hodgkin's disease, lymphomatoid papulosis, and cutaneous T-cell lymphoma derived from a common T-cell clone.
    Davis TH; Morton CC; Miller-Cassman R; Balk SP; Kadin ME
    N Engl J Med; 1992 Apr; 326(17):1115-22. PubMed ID: 1532439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuron-specific enolase (gamma enolase, gamma-gamma dimer) expression in Hodgkin's disease and large cell lymphomas.
    Massarelli G; Onida GA; Piras MA; Marras V; Mura A; Tanda F
    Anticancer Res; 1999; 19(5B):3933-8. PubMed ID: 10628334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokine production (IL-1 alpha, IL-1 beta, and TNF alpha) and endothelial cell activation (ELAM-1 and HLA-DR) in reactive lymphadenitis, Hodgkin's disease, and in non-Hodgkin's lymphomas. An immunocytochemical study.
    Ruco LP; Pomponi D; Pigott R; Stoppacciaro A; Monardo F; Uccini S; Boraschi D; Tagliabue A; Santoni A; Dejana E
    Am J Pathol; 1990 Nov; 137(5):1163-71. PubMed ID: 1700619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.